ThreatLocker
ThreatLocker Raises $190M Series F for Zero Trust Cybersecurity
ThreatLocker announced $190M in Series F financing on July 29, 2026. ThreatLocker raised a $190 million Series F led by Elephant to fund AI-related security controls, Zero Trust Platform improvements, and international expansion.
Round details
The financing includes backing from Elephant, Koch Disruptive Technologies, D. E. Shaw Ventures, Arthur Ventures. The company did not publish a valuation with the announcement.
- Round: Series F
- Capital announced: $190M
- Headquarters: Orlando, FL
How the company plans to use the capital
ThreatLocker said the capital will support continued development of its controls for AI-related security risks, further improvements to its Zero Trust Platform, and international expansion, beginning with a new office in Reading, U.K.
Why this matters for GTM teams
ThreatLocker describes its Allowlisting product as preventing unauthorized AI tools and AI-generated code from executing, and its Ringfencing product as controlling what approved applications and AI agents can access, modify and interact with.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: ThreatLocker Series F announcement.
Company Info
Investors (4)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


